Search results
Hace 4 días · Atezolizumab (Tecentriq) is an antineoplastic agent. It is formulated as solution concentrate for intravenous and solution for subcutaneous route of administration.
6 de may. de 2024 · Hoffmann-La Roche, Fritz. 1868 - 1920. Données biographiques. Nom : Hoffmann-La Roche. Prénom : Fritz. Sexe : H. Naissance : 24.10.1868. Décès : 18.04.1920. Lieu naissance : Bâle (BS) Nationalité : Suisse. Principales professions : Fondateur de Hoffmann-La Roche. Formation. Universitaire : non. base. année. titre. catégorie. lieu. pays. -
Hace 1 día · The descendant of Fritz Hoffman-La Roche the founder of drug giant Roche, joins the 2013 world billionaire ranks with an estimated individual fortune of more than $1.6 billion.
Hace 4 días · F. Hoffmann-La Roche. Atezolizumab. Share. Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Pheochromocytoma. According to GlobalData, Phase II drugs for Pheochromocytoma have a 33% phase transition success rate (PTSR) indication benchmark for progressing into Phase III.
Hace 6 días · Roche’s human papillomavirus (HPV) self-collection solution will improve access to testing by providing women the option to privately collect their own sample.
Hace 2 días · Sequencing by eXpansion (SBX) Chemistry video is a short introduction to a new technology that enables high-accuracy and high-throughput nanopore sequencing. Learn how SBX chemistry works and how it can benefit your research with Roche Sequencing Solutions.
24 de abr. de 2024 · F. Hoffmann-La Roche has patented a method for generating a module to determine analyte concentration in body fluid samples. The method involves using image data from test strips, recorded by various devices, to train a neural network model for accurate analysis.
